tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Control Bionics Reports Revenue Growth Amid Rising Losses

Story Highlights
Control Bionics Reports Revenue Growth Amid Rising Losses

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Control Bionics Ltd. ( (AU:CBL) ) has issued an announcement.

Control Bionics Limited reported a 14.84% increase in revenues to $6,144,907 for the year ending June 30, 2025, despite a 3.30% rise in losses, totaling $6,108,667. The company did not declare any dividends, and its net tangible assets per ordinary security decreased from 0.93 cents to 0.49 cents. The financial statements highlight a material uncertainty regarding the company’s ability to continue as a going concern, which may impact stakeholders’ confidence.

More about Control Bionics Ltd.

Control Bionics Limited operates in the assistive technology industry, focusing on developing and providing innovative communication and control devices for individuals with disabilities. The company is known for its products that enable users to communicate and interact with technology using neural signals, catering primarily to the healthcare and rehabilitation markets.

Average Trading Volume: 152,197

Technical Sentiment Signal: Sell

Current Market Cap: A$11.2M

Find detailed analytics on CBL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1